Rhonda Patrick· PhD
So insulin signaling goes down. So if insulin's down, all those insulin pathways that you see on your flowcharts are all going to be suppressed and IGF-1, obviously, it's going to be lower and I think that's a really important consideration to factor in as it relates to cancer therapeutics, cancer biology, cancer prevention, even. But also from the perspective of muscle metabolism. And I think by keeping insulin signaling sort of low, you upregulate factors that make you more responsive to insulin.